Snapshot from Jul 31, 2026 at 07:00 UTC. For live data and tracking: View Live
Business research announcement

Modular Medical research shows pump interest

Analysis based on 7 articles · First reported Jul 14, 2026 · Last updated Jul 14, 2026

Sentiment
20
Attention
2
Articles
7
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard

The positive survey results may boost investor confidence in Modular Medical's market opportunity for the Pivot pump, potentially supporting the stock price. However, the event is a preliminary research announcement with no immediate revenue impact, so market reaction is likely muted.

Medical Devices Diabetes Care

Modular Medical, Inc. (NASDAQ:MODD) announced positive findings from a research initiative indicating that 97% of surveyed insulin injection users would consider pump therapy if it were easier to learn and improved outcomes. The company will present the findings and showcase its Pivot tubeless insulin patch pump at the ADCES Annual Conference in August 2026. Additionally, Modular Medical has engaged Thrivable for expanded research with 320 patients to refine commercialization strategy.

70 Modular Medical announced positive findings
50 Modular Medical engaged Thrivable
40 Modular Medical launched commercially
priv
Modular Medical announced positive research findings supporting its Pivot pump commercialization strategy, potentially increasing market confidence in its product.
Importance 100.0 Sentiment 20.0
per
As CEO, Jeb Besser commented on the research results, reinforcing the company's strategic direction.
Importance 30.0 Sentiment 10.0
priv
Thrivable was engaged by Modular Medical to conduct expanded patient research, supporting product positioning.
Importance 20.0 Sentiment 5.0
cnt
The research targets the U.S. diabetes population; no direct impact on the country.
Importance 10.0 Sentiment 0.0
ngo
ADCES will host the conference where Modular Medical will present its findings; no direct impact.
Importance 10.0 Sentiment 0.0
per
Paul DiPerna is the founder of Modular Medical; mentioned in background but not directly involved in this event.
Importance 5.0 Sentiment 0.0
stock
Tandem Diabetes Care is mentioned as the prior company founded by Paul DiPerna; not directly affected.
Importance 5.0 Sentiment 0.0
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.